New smart drug targets cancer cells in advanced tumors
Disease control
Recruiting now
This early-stage trial tests OBT076, a drug that combines an antibody with a chemotherapy agent to target and kill cancer cells that have a specific protein called CD205. The study includes up to 200 adults with advanced solid tumors that have not responded to standard treatments…
Phase: PHASE1 • Sponsor: Oxford BioTherapeutics Ltd • Aim: Disease control
Last updated Jun 26, 2026 17:29 UTC